trial · primary record
Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
High-grade Glioma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2045-12 |
| Primary endpoint | Incidence of investigational treatment related severe toxicity (Dose-limiting toxicity event) |
| Registry ID | NCT06946680 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:13.492Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06946680
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.